Drugs for COVID-19: An Update

被引：21

作者：

Ceramella, Jessica ^{[1
]}

Iacopetta, Domenico ^{[1
]}

Sinicropi, Maria Stefania ^{[1
]}

Andreu, Inmaculada ^{[2
,3
]}

Mariconda, Annaluisa ^{[4
]}

Saturnino, Carmela ^{[4
]}

Giuzio, Federica ^{[4
]}

Longo, Pasquale ^{[5
]}

Aquaro, Stefano ^{[1
]}

Catalano, Alessia ^{[6
]}

机构：

[1] Univ Calabria, Dept Pharm Hlth & Nutr Sci, I-87036 Arcavacata Di Rende, Italy

[2] Univ Politecn Valencia, Dept Quim, Camino Vera s-n, Valencia 46022, Spain

[3] Hosp Univ & Politecn La Fe, Un Mixta Invest UPV IIS La Fe, Ave Fernando Abril Martorell 106, Valencia 46026, Spain

[4] Univ Basilicata, Dept Sci, I-85100 Potenza, Italy

[5] Univ Salerno, Dept Chem & Biol, Via Giovanni Paolo II,132, I-84084 Fisciano, Italy

[6] Univ Bari Aldo Moro, Dept Pharm Drug Sci, I-70126 Bari, Italy

来源：

MOLECULES | 2022年 / 27卷 / 23期

关键词：

antibiotics; anticoagulants; antivirals; COVID-19; interleukin inhibitors; JAKs inhibitors; immunomodulators; NSAIDs; SARS-CoV-2; HYDROXYCHLOROQUINE;

D O I：

10.3390/molecules27238562

中图分类号：

Q5 [生物化学]; Q7 [分子生物学];

学科分类号：

071010 ; 081704 ;

摘要：

The severe acute respiratory syndrome coronavirus 2 (SARS-CoV-2) was the seventh known human coronavirus, and it was identified in Wuhan, Hubei province, China, in 2020. It caused the highly contagious disease called coronavirus disease 2019 (COVID-19), declared a global pandemic by the World Health Organization (WHO) on 11 March 2020. A great number of studies in the search of new therapies and vaccines have been carried out in these three long years, producing a series of successes; however, the need for more effective vaccines, therapies and other solutions is still being pursued. This review represents a tracking shot of the current pharmacological therapies used for the treatment of COVID-19.

引用

页数：17

共 98 条

[71] Omicron sublineage BA.2.75.2 exhibits extensive escape from neutralising antibodies [J].

Sheward, Daniel J. ;

Kim, Changil ;

Fischbach, Julian ;

Sato, Kenta ;

Muschiol, Sandra ;

Ehling, Roy A. ;

Bjorkstrom, Niklas K. ;

Hedestam, Gunilla B. Karlsson ;

Reddy, Sai T. ;

Albert, Jan ;

Peacock, Thomas P. ;

Murrell, Ben .

LANCET INFECTIOUS DISEASES, 2022, 22 (11) :1538-1540

[72] Efficacy and Safety of Favipiravir in Moderate COVID-19 Pneumonia Patients without Oxygen Therapy: A Randomized, Phase III Clinical Trial [J].

Shinkai, Masaharu ;

Tsushima, Kenji ;

Tanaka, Shingo ;

Hagiwara, Eri ;

Tarumoto, Norihito ;

Kawada, Ichiro ;

Hirai, Yuji ;

Fujiwara, Sho ;

Komase, Yuko ;

Saraya, Takeshi ;

Koh, Hidefumi ;

Kagiyama, Naho ;

Shimada, Megumi ;

Kanou, Daiki ;

Antoku, Shinichi ;

Uchida, Yujiro ;

Tokue, Yutaka ;

Takamori, Mikio ;

Gon, Yasuhiro ;

Ie, Kenya ;

Yamazaki, Yoshitaka ;

Harada, Kazumasa ;

Miyao, Naoki ;

Naka, Takashi ;

Iwata, Mitsunaga ;

Nakagawa, Atsushi ;

Hiyama, Kazutoshi ;

Ogawa, Yoshihiko ;

Shinoda, Masahiro ;

Ota, Shinichiro ;

Hirouchi, Takatomo ;

Terada, Jiro ;

Kawano, Shuichi ;

Ogura, Takashi ;

Sakurai, Tsutomu ;

Matsumoto, Yoshihiko ;

Kunishima, Hiroyuki ;

Kobayashi, Osamu ;

Iwata, Satoshi .

INFECTIOUS DISEASES AND THERAPY, 2021, 10 (04) :2489-2509

[73] Molnupiravir in COVID-19: A systematic review of literature [J].

Singh, Awadhesh Kumar ;

Singh, Akriti ;

Singh, Ritu ;

Misra, Anoop .

DIABETES & METABOLIC SYNDROME-CLINICAL RESEARCH & REVIEWS, 2021, 15 (06)

[74] Drug repurposing approach to fight COVID-19 [J].

Singh, Thakur Uttam ;

Parida, Subhashree ;

Lingaraju, Madhu Cholenahalli ;

Kesavan, Manickam ;

Kumar, Dinesh ;

Singh, Raj Kumar .

PHARMACOLOGICAL REPORTS, 2020, 72 (06) :1479-1508

[75] Azithromycin and hydroxychloroquine in hospitalised patients with confirmed COVID-19: a randomised double-blinded placebo-controlled trial [J].

Sivapalan, Pradeesh ;

Ulrik, Charlotte Suppli ;

Lapperre, Therese Sophie ;

Bojesen, Rasmus Dahlin ;

Eklof, Josefin ;

Browatzki, Andrea ;

Wilcke, Jon Torgny ;

Gottlieb, Vibeke ;

Hakansson, Kjell Erik Julius ;

Tidemandsen, Casper ;

Tupper, Oliver ;

Meteran, Howraman ;

Bergsoe, Christina ;

Brondum, Eva ;

Bodtger, Uffe ;

Rasmussen, Daniel Bech ;

Jensen, Sidse Graff ;

Pedersen, Lars ;

Jordan, Alexander ;

Prieme, Helene ;

Soborg, Christian ;

Steffensen, Ida E. ;

Hogsberg, Dorthe ;

Klausen, Tobias Wirenfeldt ;

Frydland, Martin Steen ;

Lange, Peter ;

Sverrild, Asger ;

Ghanizada, Muhzda ;

Knop, Filip K. ;

Biering-Sorensen, Tor ;

Lundgren, Jens D. ;

Jensen, Jens-Ulrik Staehr .

EUROPEAN RESPIRATORY JOURNAL, 2022, 59 (01)

[76] Recent Progress in the Development of Opaganib for the Treatment of Covid-19 [J].

Smith, Charles ;

Maines, Lynn W. ;

Keller, Staci N. ;

Ben-Yair, Vered Katz ;

Fathi, Reza ;

Plasse, Terry F. ;

Levitt, Mark L. .

DRUG DESIGN DEVELOPMENT AND THERAPY, 2022, 16 :2199-2211

[77] Treatment for COVID-19: An overview [J].

Stasi, Cristina ;

Fallani, Silvia ;

Voller, Fabio ;

Silvestri, Caterina .

EUROPEAN JOURNAL OF PHARMACOLOGY, 2020, 889

[78] Azithromycin in COVID-19 Patients: Pharmacological Mechanism, Clinical Evidence and Prescribing Guidelines [J].

Sultana, Janet ;

Cutroneo, Paola Maria ;

Crisafulli, Salvatore ;

Puglisi, Gabriele ;

Caramori, Gaetano ;

Trifiro, Gianluca .

DRUG SAFETY, 2020, 43 (08) :691-698

[79] Molnupiravir: First Approval [J].

Syed, Yahiya Y. .

DRUGS, 2022, 82 (04) :455-460

[80] A review of potential suggested drugs for coronavirus disease (COVID-19) treatment [J].

Tarighi, Parastoo ;

Eftekhari, Samane ;

Chizari, Milad ;

Sabernavaei, Mahsa ;

Jafari, Davod ;

Mirzabeigi, Parastoo .

EUROPEAN JOURNAL OF PHARMACOLOGY, 2021, 895

← 1 2 3 4 5 6 7 8 9 10 →